Qube Research & Technologies LTD Vigil Neuroscience, Inc. Transaction History
Qube Research & Technologies LTD
- $82.3 Billion
- Q1 2025
A detailed history of Qube Research & Technologies LTD transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 31,570 shares of VIGL stock, worth $249,718. This represents 0.0% of its overall portfolio holdings.
Number of Shares
31,570
Previous 108,482
70.9%
Holding current value
$249,718
Previous $182,000
69.23%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VIGL
# of Institutions
52Shares Held
29.3MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$46.2 Million3.04% of portfolio
-
Northpond Ventures, LLC4.21MShares$33.3 Million51.65% of portfolio
-
Bvf Inc San Francisco, CA4.01MShares$31.7 Million0.31% of portfolio
-
Siren, L.L.C. New York, NY1.97MShares$15.6 Million0.2% of portfolio
-
683 Capital Management, LLC New York, NY1.74MShares$13.8 Million0.25% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $224M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...